Pharmaron shareholders trim stakes, triggering disclosure threshold

Pharmaron Beijing announced that two of its major shareholders, Shenzhen Zhongkang Investment Partnership (Zhongkang) and Shenzhen Zhonglong Investment Partnership (Zhonglong), have collectively reduced their holdings, triggering a 1% integer multiple threshold. Between July 10, 2025, and December 10, 2025, Zhongkang and Zhonglong together disposed of 17,782,019 shares. This included Zhongkang selling 6,642,829 shares through centralized bidding and 8,910,690 shares via block trades, while Zhonglong sold 2,228,500 shares through centralized bidding.

Prior to these transactions, Zhongkang held 238,230,829 shares, representing 13.40% of the total share capital, and Zhonglong held 28,498,500 shares, representing 1.60%. After the reduction, Zhongkang's stake decreased to 222,677,310 shares (12.52%), and Zhonglong's to 26,270,000 shares (1.48%). Cumulatively, their combined ownership in Pharmaron Beijing now stands at 14.00% from an initial 15.00%.

The company confirmed that this shareholding change is consistent with previously disclosed plans. The share reductions were carried out to address the shareholders' capital requirements and are not expected to impact the company's governance structure or ongoing operations.